Copertina

Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sara Darbandi, Alfonso Urbanucci, Sini Hakkola, Juanita Gujral, Mahsa Darbandi, Ahmed Eraky, Sujit Nair, Goutam Chakraborty, Ashutosh Tewari, Natasha Kyprianou
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	The Prostate
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Link between circadian rhythm and benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS)
di: Dana Cavanaugh, et al.
Pubblicazione: (2024)

Impact of Genomic Mutations on the Transcriptional Pathways and Tumor Microenvironment Landscape of Localized Early Prostate Cancer
di: William Lautert‐Dutra, et al.
Pubblicazione: (2026)

IL7 as a Risk Factor for Prostate Cancer: Implications for T Cell Apoptosis and Infiltration in the Tumor Microenvironment
di: Enyang He, et al.
Pubblicazione: (2024)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
di: Tatsuya Shimomura, et al.
Pubblicazione: (2026)

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
di: Hyun‐Kyung Ko, et al.
Pubblicazione: (2025)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
di: Marta Victoria Lorenzo‐Sánchez, et al.
Pubblicazione: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
di: Elizabeth Robinson, et al.
Pubblicazione: (2025)

The Impact of Tumor Microenvironmental Acidity on Bicalutamide Sensitivity in Prostate Cancer Cells
di: Pedram Golmohammadi, et al.
Pubblicazione: (2026)

Altered Ten Eleven Translocation Methylcytosine Dioxygenase Expression and DNA Hydroxymethylation in a Mouse Model of Prostate Cancer
di: Matthew Aguilera, et al.
Pubblicazione: (2025)

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance
di: Marco Oderda, et al.
Pubblicazione: (2025)

A Gene Expression Tumor Signature Optimizing Partial Area‐Under‐the‐Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer
di: Travis A. Gerke, et al.
Pubblicazione: (2026)

Correction to “Resveratrol Inhibits the Tumor Migration and Invasion by Upregulating TET1 and Reducing TIMP2/3 Methylation In Prostate Carcinoma Cells”
Pubblicazione: (2025)

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
di: Shengyi Chen, et al.
Pubblicazione: (2025)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
di: Amr M. Lotfy, et al.
Pubblicazione: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
di: Yifu Shi, et al.
Pubblicazione: (2025)

Discovering the Prostate: Notes on History and Historiography
di: Diederik F. Janssen
Pubblicazione: (2025)

Evidence and Rationale for Prostate Cancer Screening
di: Takeshi Takahashi
Pubblicazione: (2025)

Spatial Characteristics of Intraductal Carcinoma of the Prostate
di: Rodolphe Dupuis, et al.
Pubblicazione: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
di: Charly Bâcle, et al.
Pubblicazione: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
di: Giuston Mendoza‐Chuctaya, et al.
Pubblicazione: (2025)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
di: Ahmed Yehia Abdelaziz, et al.
Pubblicazione: (2024)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
di: Christian Andrés Martínez Osorio, et al.
Pubblicazione: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
di: Cameron J. Britton, et al.
Pubblicazione: (2025)

Mycobacterium Tuberculosis: The Hidden Bacteria in Chronic Prostatitis
di: André Avarese Figueiredo, et al.
Pubblicazione: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
di: Hannu Koistinen, et al.
Pubblicazione: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
di: Sheila Jonnatan, et al.
Pubblicazione: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
di: Andrea K. Miyahira, et al.
Pubblicazione: (2024)

MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer
di: Masashi Tsujimoto, et al.
Pubblicazione: (2025)

Pathology of a Canine Model of Localized Prostate Carcinoma
di: Nathan K. Hoggard, et al.
Pubblicazione: (2025)

Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study
di: Ezra G. Baraban, et al.
Pubblicazione: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
di: Reid Vassallo, et al.
Pubblicazione: (2025)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
di: Liza M. Kurucz, et al.
Pubblicazione: (2025)

Serum Levels of Prostate Specific Antigen, Free PSA, [‐2]proPSA, fPSA/tPSA Ratio, Prostate Health Index, and Glycosylation Patterns of Free PSA in Patients With Benign Prostatic Hyperplasia Pharmacotherapy: Limitations and Future Directions
di: Yitong Weng, et al.
Pubblicazione: (2025)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
di: Takanori Tokunaga, et al.
Pubblicazione: (2025)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
di: Yuto Ono, et al.
Pubblicazione: (2025)

Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
di: Victor Sandoval, et al.
Pubblicazione: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
di: Haotian Chen, et al.
Pubblicazione: (2025)

Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes
di: Christian P. Pavlovich, et al.
Pubblicazione: (2025)

Coconut Oil Mitigates the Effects of Aging on the Mongolian Gerbil Prostate
di: Luiz Henrique Alves Guerra, et al.
Pubblicazione: (2024)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics
di: Kristofer G. Taylor, et al.
Pubblicazione: (2026)